APA (7th ed.) Citation

Dong, W., Wang, Y., Li, H., Ma, H., Gong, Y., Luo, G., & Gao, X. (2025). Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. MDPI AG.

Chicago Style (17th ed.) Citation

Dong, Wenran, Ying Wang, Huajinzi Li, Huilin Ma, Yingxi Gong, Gan Luo, and Xiaoyan Gao. Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. MDPI AG, 2025.

MLA (9th ed.) Citation

Dong, Wenran, et al. Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome. MDPI AG, 2025.